Share This Post

Cabozantinib improves outcomes for patients without reducing quality of life

Read more here:

Share This Post

Dena Battle is the President of KCCure. She also serves on the Advisory Board for the Johns Hopkins Sidney Kimmel Cancer Center and as a member of the Patient and Family Advisory Council.

Lost Password


Subscribe for updates!